Cargando…
α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease
BACKGROUND: The disintegrin metalloproteinase 10 (ADAM10) is the main α-secretase acting in the non-amyloidogenic processing of APP. Some ADAM10 gene variants have been associated with higher susceptibility to develop late-onset AD, though clear clinical-genetic correlates remain elusive. METHODS: C...
Autores principales: | Agüero, Pablo, Sainz, María José, García-Ayllón, María-Salud, Sáez-Valero, Javier, Téllez, Raquel, Guerrero-López, Rosa, Pérez-Pérez, Julián, Jiménez-Escrig, Adriano, Gómez-Tortosa, Estrella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603780/ https://www.ncbi.nlm.nih.gov/pubmed/33129344 http://dx.doi.org/10.1186/s13195-020-00708-0 |
Ejemplares similares
-
ADAM10 Gene Variants in AD Patients and Their Relationship to CSF Protein Levels
por: Agüero-Rabes, Pablo, et al.
Publicado: (2023) -
Inhibition of γ-Secretase Leads to an Increase in Presenilin-1
por: Sogorb-Esteve, Aitana, et al.
Publicado: (2017) -
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
por: Sogorb-Esteve, Aitana, et al.
Publicado: (2018) -
Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer’s Disease Treatment
por: Peron, Rafaela, et al.
Publicado: (2018) -
Revisiting the Role of Acetylcholinesterase in Alzheimer’s Disease: Cross-Talk with P-tau and β-Amyloid
por: García-Ayllón, María-Salud, et al.
Publicado: (2011)